A judge has set a tentative trial date for early next year for …
A judge has set a tentative trial date for early next year for …
The Boston Bruins are on the brink of the Eastern Conference …
Updated: Saturday, 17 Nov 2012, 9:27 PM EST
Published : Saturday, 17 Nov 2012, 8:52 PM EST
BOSTON (AP) - Massachusetts is getting more than $2.1 million to settle claims that British drug maker Glaxo-Smith-Kline LLC deceptively promoted the diabetes drug Avandia.
The payment is part of a $90 million settlement between Glaxo-Smith-Kline and attorney generals from 38 different states.
Attorney General Martha Coakley's office says the Massachusetts share of the settlement will mostly fund programs to lower health care costs for residents, combat unlawful marketing practices in the health care market or benefit consumers.
Attorney generals say Glaxo-Smith-Kline misrepresented Avandia's cardiovascular risks and safety profile.
Advertisement